Flexeril and Adcirca drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Flexeril (cyclobenzaprine hydrochloride) and Adcirca (tadalafil). Common drug interactions include abdominal distension among females and oedema among males.

The phase IV clinical study analyzes what interactions people have when they take Flexeril and Adcirca. It is created by eHealthMe based on reports of 70 people who take the same drugs from the FDA, and is updated regularly.

What is Flexeril?

Flexeril has active ingredients of cyclobenzaprine hydrochloride. It is often used in muscle spasms. eHealthMe is studying from 38,308 Flexeril users. Check the latest studies of Flexeril.

What is Adcirca?

Adcirca has active ingredients of tadalafil. It is often used in pulmonary hypertension. eHealthMe is studying from 54,957 Adcirca users. Check the latest studies of Adcirca.



On Jul, 16, 2026

70 people who take Flexeril and Adcirca together, and have interactions are studied.

Flexeril and Adcirca drug interactions.

What are the common drug interactions of Flexeril and Adcirca, by gender? *:

female:

  1. Abdominal distension
  2. Abdominal pain
  3. Abscess (pus)
  4. Acute respiratory failure
  5. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  6. Arthralgia (joint pain)
  7. Ascites (accumulation of fluid in the abdominal cavity)
  8. Bladder cancer
  9. Brain neoplasm (tumour of brain)
  10. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)

male:

  1. Oedema (fluid collection in tissue)
  2. Weight increased
  3. Fatigue (feeling of tiredness)
  4. Fluid overload (too much fluid in the blood)
  5. Glomerular filtration rate decreased
  6. Hypokinesia (decreased bodily movement)
  7. Hypotension (abnormally low blood pressure)
  8. Insulin-requiring type 2 diabetes mellitus
  9. Limb injury
  10. Lung cancer metastatic (lung cancer spreads to other parts)

What are the common drug interactions of Flexeril and Adcirca, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Anaemia (lack of blood)
  2. Gastric antral vascular ectasia (blood vessels in the lining of the stomach become fragile and become prone to rupture and bleeding)
  3. Gastric disorder (disease of stomach)
  4. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  5. Thrombocytopenia (decrease of platelets in blood)

40-49:

  1. Nausea (feeling of having an urge to vomit)
  2. Migraine (headache)
  3. Palpitations (feelings or sensations that your heart is pounding or racing)
  4. Diarrhoea
  5. Dyspnoea (difficult or laboured respiration)
  6. Headache (pain in head)
  7. Pain
  8. Pain in jaw
  9. Burning sensation
  10. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)

50-59:

  1. Nausea (feeling of having an urge to vomit)
  2. Palpitations (feelings or sensations that your heart is pounding or racing)
  3. Anxiety
  4. Appetite disorder (abnormal eating habits)
  5. Asthenia (weakness)
  6. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  7. Deafness
  8. Drug administration error
  9. Fatigue (feeling of tiredness)
  10. Pain in extremity

60+:

  1. Dyspnoea (difficult or laboured respiration)
  2. Headache (pain in head)
  3. Eye irritation
  4. Fluid retention (an abnormal accumulation of fluid in the blood)
  5. Flushing (the warm, red condition of human skin)
  6. Hip arthroplasty
  7. Osteoporosis (bones weak and more likely to break)
  8. Oxygen saturation decreased
  9. Pain in extremity
  10. Respiratory tract congestion (blockage on respiratory system)

What are the existing conditions these people have? *

  1. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 49 people, 70.00%
  2. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 5.71%

* Approximation only. Some reports may have incomplete information.

Do you take Flexeril and Adcirca?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Flexeril and Adcirca:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Flexeril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Adcirca:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Flexeril and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Adcirca and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cyclobenzaprine hydrochloride and tadalafil (the active ingredients of Flexeril and Adcirca, respectively), and Flexeril and Adcirca (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: